You are here

Pharma firms must stay healthy to win vaccine race

India companies have slim chance of success without government or donor funding, but stocks surge is a good sign as they rush to find cure for Covid-10 pandemic.

Even after receiving funds for clinical trials and creating manufacturing facilities, pharmaceutical companies are not sure they will be able to earn much.

THE race to produce a vaccine against the novel coronavirus is featuring five Indian multinational pharmaceuticals and biotech companies and two research institutes that are aiming to deliver vaccines and super drugs at prices much below their global counterparts. So far, more than 40 companies...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to